From February 26th to 27th, Caszyme CEO Monika Paule will attend the Sachs Associates 18th Annual European Life Sciences CEO Forum in Zurich.
She will also participate in the New Modalities Panel: The Future of Gene Editing on February 26th, 2025 at 4 PM CET. Alongside other industry leaders, Monika will discuss the latest advancements in gene editing, its impact on treatment options, and key ethical considerations.
If you’d like to meet with Monika at Sachs_ELSF to explore the potential of CRISPR solutions, feel free to reach out via DM.
